Sofia Lysenko’s parents moved to the United States from the Ukraine when she was 3 years old. Today, at 17, some of the biggest American pharmaceutical companies want to team up with this teenage science prodigy because she has created an artificial macromolecule robot that can deliver drugs directly to the brain cells of patients with Alzheimer’s and Parkinson’s. Iryna Matviichuk met with Sofia to learn more. Anna Rice narrates her report.
Joolam skype chat
news
- Senate intelligence panel criticizes CIA response to Havana syndrome 12/27/2024
- US sanctions founder of Georgia’s ruling political party 12/27/2024
- Ukraine tech company presents latest military simulators 12/27/2024
- Massive Chinese espionage scheme hit 9th telecom firm, US says 12/27/2024
- What will US immigration look like under Trump? 12/27/2024
subscribe via email
Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookie Policy
To find out more, including how to control cookies, see here: Cookie Policy